In PK studies of parenteral islatravir in rodents, continuous duration of drug release (owing to the recycling of drug accomplished by translocation inhibition) was observed after 180 days (27)
In PK studies of parenteral islatravir in rodents, continuous duration of drug release (owing to the recycling of drug accomplished by translocation inhibition) was observed after 180 days (27). inhibitors began in 2003 (9), clinically relevant drugs did not reach demonstration in the public website until recently. Data for GS-CA1 was first presented in the…